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Brief Definit ive Report
Rheumatoid arthritis (RA) is characterized by 
an immune-mediated destruction of joint tissue 
caused by chronic inflammation of the synovium 
(Manzo et al., 2010). Synovitis in RA is highly 
heterogeneous and is classified according to 
specific histological features (Klimiuk et al., 
1997; Pitzalis et al., 2013). In RA, synovial his-
topathology is defined as fibroblast- (or pauci 
immune), diffuse-, or lymphoid-rich. The latter 
is characterized as lymphoid follicle-like struc-
tures ranging from T and B cell aggregates to 
highly organized structures comprising follicular 
DC (fDC) networks reminiscent of germinal cen-
ters (GCs). These structures are present in 40% 
of RA patients (Manzo et al., 2010; Pitzalis et al., 
2013) and are associated with severe disease, 
T cell priming, and autoantibody production 
(Takemura et al., 2001; Rosengren et al., 2008; 
Humby et al., 2009). Although circulating rheu-
matoid factor (RF) and anticitrullinated pro-
tein antibodies (ACPA) correlate with disease 
severity (Avouac et al., 2006), these clinical mark-
ers unreliably predict synovial pathology.
IL-27 is a regulator of adaptive immunity 
and limits T cell–driven pathology by restrict-
ing IL-2 activity and the expansion of IL-17–
secreting T helper 17 (Th17) cells (Villarino 
et al., 2003; Owaki et al., 2006; Stumhofer et al., 
2006). Recently, Th17 cells were shown to 
enhance ectopic lymphoid-like structure (ELS) 
formation in inflamed tissues (Peters et al., 
2011; Rangel-Moreno et al., 2011). Indeed, 
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Ectopic lymphoid-like structures (ELSs) reminiscent of secondary lymphoid organs often 
develop at sites of chronic inflammation where they contribute to immune-mediated 
pathology. Through evaluation of synovial tissues from rheumatoid arthritis (RA) patients, 
we now show that low interleukin-27 (IL-27) expression corresponds with an increased 
incidence of ELS and gene signatures associated with their development and activity. The 
presence of synovial ELS was also noted in mice deficient in the IL-27 receptor (IL-27R) 
after the onset of inflammatory arthritis. Here, pathology was associated with increased 
synovial expression of pro-inflammatory cytokines, homeostatic chemokines, and transcrip-
tional regulators linked with lymphoid neogenesis. In both clinical and experimental RA, 
synovial ELS coincided with the heightened local expression of cytokines and transcription 
factors of the Th17 and T follicular helper (Tfh) cell lineages, and included podoplanin-
expressing T cells within lymphoid aggregates. IL-27 inhibited the differentiation of  
podoplanin-expressing Th17 cells, and an increased number of these cells were observed in 
IL-27R–deficient mice with inflammatory arthritis. Thus, IL-27 appears to negatively 
regulate ELS development in RA through control of effector T cells. These studies open new 
opportunities for patient stratification and treatment.
© 2015 Jones et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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IL-6 cytokine family. To evaluate how IL-27R expression 
relates to local joint pathology, RA synovia were graded his-
tologically for the presence or absence of ELS (Fig. 1 A and 
Fig. S1). Tissue with grade-3 (G3) ELS aggregates compris-
ing CD3+, CD20+, and CD21+ cells (ELS+) were compared 
with biopsies displaying diffuse lymphocytic infiltrates (ELS). 
To validate our cellular characterization, expression of key 
homeostatic chemokines, cytokines, and molecular signatures 
of ELS were evaluated (Timmer et al., 2007; Humby et al., 
2009). Consistent with the presence of lymphoid follicles, 
heightened CXCL13, CCL19, and CXCR5 expression was 
observed in ELS+ patient biopsies (Fig. 1 B). Elevated tran-
scripts for activation-induced cytidine deaminase (AID), an 
enzyme involved in somatic hypermutation and class switching, 
was also observed (Fig. 1 B). Consistent with the presence of 
CD21+ fDC networks detected by immunohistochemistry 
Th17 cell plasticity permits the acquisition of Tfh-like effector 
characteristics that support ELS expansion and GC reactions 
(Lu et al., 2011; Peters et al., 2011; Hirota et al., 2013). In 
models of inflammatory arthritis, IL-27 blocks Th17-associated 
joint pathology (Niedbala et al., 2008; Pickens et al., 2011) and 
inhibits osteoclastogenesis to restrict bone erosion (Kalliolias 
et al., 2010). While elevated synovial and serum IL-27 levels 
have been observed in RA (Wong et al., 2010; Tanida et al., 
2011), no study has considered the impact of IL-27 on syno-
vial histopathology. Here, we show that IL-27 control of CD4 
T cell responses prevents the development of synovial ELS.
RESULTS AND DISCUSSION
Synovial ELSs in RA contain IL-27R+ lymphocytic aggregates
The IL-27 receptor comprises a heterodimeric complex of 
IL-27R (WSX-1) and gp130, the -signaling receptor of the 
Figure 1. IL-27R is expressed at synovial 
ELS. (A) Representative histopathology of RA 
synovium from 59 patients with ELS (ELS+) and 
diffuse pathology (ELS). Sequential sections 
were stained as indicated by IHC. (B) qPCR 
analysis of ELS+ and ELS synovia for the indi-
cated genes (number of patients: CXCL13 and 
AID, n = 34 ELS+, n = 24 ELS; CXCR5, CD21L, 
and LTB, n = 28 ELS+, n = 20 ELS; CCL19 and 
CCL21, n = 13 ELS+, n = 12 ELS; CXCL12,  
n = 15 ELS+, n = 8 ELS). (C) IL27RA expression 
in ELS+ and ELS RA synovia. Synovial tissue 
from OA patients was used as control (error 
bars, SEM; n = 19 ELS+, n = 13 ELS, n = 11 OA 
patients). (D) Detection of IL-27R in tonsil GCs 
(left) and synovial ELS (right) by IF for IL-27R 
and CD3, and DAPI counterstaining. Images are 
representative of three tissue samples. (E) IF 
for IL-27R and CD3 with DAPI nuclear staining 
in synovial ELS. Error bars indicate SEM. *,  
P < 0.05; **, P < 0.01; ***, P < 0.001. Bars:  
(A) 200 µm; (D and E) 50 µm.
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Pickens et al., 2011). Increased arthritis severity in Il27ra/ 
mice was also linked with heightened adaptive immune re-
sponses. Specifically, Il27ra/ mice showed elevated antigen 
(mBSA)-specific serum IgG titers (Fig. 2 D), increased Th17 cell 
numbers in draining LNs (Fig. 2 E), and a concomitant in-
crease in serum IL-17 levels early after disease onset (Fig. 2 F).
Exacerbated synovitis in IL-27R deficiency is linked  
with ELS development
Based on IL-27 bioactivity and the pattern of IL-27R expres-
sion in human synovial biopsies, we next assessed the impact 
of IL-27R deficiency on the pattern of synovitis. Il27ra/ 
mice with AIA showed heightened synovial T cell infiltra-
tion and the presence of discrete CD3+ aggregates through-
out the synovium (Fig. 3 A). Whereas a small proportion of 
mice presented with small aggregates at d3 after AIA (not de-
picted), by d10 all Il27ra/ mice developed multiple lym-
phoid aggregates (7.1 ± 0.8 per synovial section and 12.8 × 
104 ± 1.7 µm2 in size; Fig. 3, A and B). WT mice developed 
a more diffuse pattern of synovial inflammation and showed 
significantly fewer lymphoid aggregates. When present, these 
were both smaller in size and less organized (1.9 ± 0.4 per sy-
novial section and 1.6 × 104 ± 0.5 µm2 in size; Fig. 3 B). 
Although the inflamed synovium of Il27ra/ mice showed a 
paucity of B220+ cells, IHC staining for B cells colocalized 
with the defined CD3+-rich aggregates (Fig. 3 C). However, 
the degree of B cell involvement often varied between 
aggregates (e.g., compare Fig. 3 C and Fig. 5 A). Although 
(IHC), ELS+ synovia showed expression of the long CD21 
isoform (CD21L; Fig. 1 B). Heightened expression of lym-
photoxin- (LTB), a cytokine linked with lymphoid neogene-
sis, was also observed in ELS+ synovia (Fig. 1 B). Interestingly, 
IL27RA expression was increased in ELS+ patient synovia 
compared with ELS and osteoarthritis (OA) control tissue 
(Fig. 1 C). Consistent with the pattern of IL-27R staining 
seen in tonsil tissue displaying highly organized GCs, immuno-
fluorescence (IF) revealed IL-27R+ cells within synovial ELS 
(Fig. 1 D). Here, IL-27R expression was largely observed in 
T cell–rich areas of lymphoid aggregates (Fig. 1 E). Thus, 
IL-27 may impact synovial ELS development or associated 
effector T cell activities.
IL-27R–deficient mice display severe inflammatory arthritis
To consider the impact of IL-27 on inflammatory arthritis, dis-
ease activity was monitored in WT and Il27ra/ mice after 
the onset of antigen-induced arthritis (AIA; Nowell et al., 
2009). Il27ra/ mice displayed exacerbated joint pathology, 
as indicated by increases in leukocyte infiltration, synovial exu-
date, hypertrophy, and hallmarks of cartilage and bone erosion 
(Fig. 2, A–C). By day 35 (d35) of AIA, WT and Il27ra/ mice 
displayed extensive cartilage degradation. However, an in-
creased incidence of focal bone erosions was seen in Il27ra/ 
mice (Fig. 2, A and C). These findings reveal a protective 
role for IL-27 in AIA and support the ability of IL-27 to in-
hibit RANKL-dependent and -independent osteoclastogenic 
bone erosion (Niedbala et al., 2008; Kalliolias et al., 2010; 
Figure 2. IL-27 is protective in inflam-
matory arthritis. (A) Histopathology scoring 
of AIA in WT and Il27ra/ mice, showing 
arthritic index, synovial infiltration, exudate, 
and erosion at d3 (n = 6–7/group), d10  
(n = 13/group), and d35 (n = 14–15/group).  
(B) Representative H&E of knee joints at d10 
of AIA; boxed areas show extensive subsyno-
vial inflammation (large box) and focal bone 
erosions (small box) in Il27ra/ mice. 
Noninflamed control joints are shown on the 
right. (C) Representative images of cartilage 
degradation and bone erosion, seen as loss 
of red Safranin O staining of the articular 
cartilage. Boxes show focal bone erosions. 
(D) Anti-mBSA serum titers at d3 (n = 6–7/
group), d10 (n = 5/group), and d35 (n = 6–8/
group). (E) Number of IFN-– and IL-17– 
producing CD4 T cells in inguinal LNs deter-
mined by flow cytometry at d3 (n = 6–7/group), 
d10 (n = 8/group), and d35 (n = 14–15/group).  
(F) ELISA of serum IL-17 at d3 (n = 6–7/group) 
and d10 (n = 12–13/group) of AIA. Error bars 
indicate SEM. *, P < 0.05; **, P < 0.01; ***,  
P < 0.001. Data are presented from two inde-
pendent experiments per time point. Bars:  
(B) 500 µm; (C) 300 µm.
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lymphoid cells within ELS (Luther et al., 2000; Chen et al., 
2002). In contrast, synovial Ccl19 expression was reduced in 
IL-27R deficiency. Although CCL19 and CCL21 share a 
common chemokine receptor (CCR7), they have a differen-
tial impact on composition and cellular organization of ELS 
(Luther et al., 2002; Haynes et al., 2007). Thus, relative dif-
ferences in Ccl19 and Ccl21 expression within the inflamed 
synovium of Il27ra/ mice may promote the CD3-rich na-
ture of the observed ELS. By d10 of AIA, once ELSs were 
formed, expression of Cxcl13 and Ccl21 were comparable 
between WT and Il27ra/ mice (Fig. 4 A). However, at this 
later time point, increased expression of the lymphoneogenic 
cytokines LT and LT (Lta and Ltb) was observed in 
Il27ra/ mice (Fig. 4 A). Similarly, synovial Prdm1 (Blimp1) 
expression, which supports B cell differentiation into anti-
body-secreting plasma cells, was also heightened in Il27ra/ 
mice at d10 (Fig. 4 A). These data are consistent with in-
creased Prdm1 expression in ectopic GCs after cytomegalovi-
rus infection of salivary glands (Grewal et al., 2011). Thus, 
F4/80+ myeloid cells were largely restricted to areas surround-
ing the lymphoid rich zones (Fig. 3 C), IHC detected the 
transcriptional regulator of Tfh cells and GC B cells, Bcl-6, and 
the fDC marker CD21 within their composition (Fig. 3, 
D and E). Thus, lymphoid aggregates in the inflamed 
synovium of Il27ra/ mice resemble ELS.
To explore the initiation of ELS formation, we examined 
synovial expression of cytokines (Il6, Il21, Ltb, and Vegf), ho-
meostatic chemokines (Cxcl12, Cxcl13, Ccl19, and Ccl21), 
and transcriptional regulators (Bcl6 and Prdm1) linked with 
ectopic lymphoid neogenesis at d3 of AIA (Fig. 3 F; Manzo 
et al., 2005, 2010; Barone et al., 2008). Consistent with the 
presence of Bcl-6+ lymphoid aggregates in Il27ra/ mice, 
qPCR analysis showed increased synovial expression of Bcl6 
as compared with WT controls. No difference in Il6, Il21, 
Ltb, Vegf, Cxcl12, or Prdm1 was seen between WT and 
Il27ra/ mice (Fig. 3 F). Increased Bcl6 expression was, 
however, accompanied by enhanced Cxcl13 and Ccl21 ex-
pression (Fig. 3 F), which steers the spatial organization of 
Figure 3. Il27ra/ mice develop synovial 
ELS-like pathology. (A–F) AIA was estab-
lished in WT and Il27ra/ mice and histopa-
thology assessed at d10. (A) Representative 
IHC and quantification of CD3 staining in 
synovial sections (n = 11–13/group). (B) The 
number (left) and area (right) of lymphoid 
aggregates were quantified in para-sagital 
synovial sections (n = 27–29/group). (C) Serial 
sections from Il27ra/ mice were stained for 
CD3, F4/80, and B220. Aggregates in sequen-
tial sections are shown boxed. (D and E) Serial 
sections from Il27ra/ mice stained for CD3 
and Bcl-6 (D) and CD3 and CD21 cells (E).  
(F) qPCR of indicated genes in WT and 
Il27ra/ mouse synovium at d3 of AIA  
(n = 5–6/group). Error bars indicate SEM.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001. Data are 
representative of two (A, C, D, E, and F) and 
four (B) independent experiments. Bars:  
(A and C) 200 µm; (D–E) 100 µm.
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phosphorylated (pY)-STAT3 in Il27ra/ mice revealed 
a high degree of STAT3 activity (Fig. 4 C). However, 
pY-STAT3 staining localized with diffuse infiltrates through-
out the synovium and was not confined to ELS. Thus, local-
ized STAT3 activity is an unreliable indicator of ELS and is 
consistent with the broader roles of STAT3 in governing 
chronic inflammation (Atsumi et al., 2002; Sawa et al., 2006; 
Nowell et al., 2009).
Recent studies have identified effector Th17 cells with 
Tfh-like properties that express the glycoprotein podoplanin 
(Pdp; gp38; Peters et al., 2011; Hirota et al., 2013). These cells 
contribute to ELS development in autoimmunity and GC 
reactions (Peters et al., 2011; Hirota et al., 2013; Miyamoto 
et al., 2013). Because Il27ra/ mice show heightened periph-
eral Th17 responses (Fig. 2, E and F) and the local expression 
of Th17/Tfh markers during AIA (Figs. 3, D and E, and 4 B), 
we examined if synovial ELS development was linked to 
infiltrating Pdp-expressing T cells. Synovial tissue from AIA-
challenged Il27ra/ mice showed Pdp+ cells colocalizing 
with B220+ and CD3+ cells at ELS (Fig. 5 A). Although Pdp+ 
cells were enriched at ELS, staining was also seen in other areas 
(e.g., synovial lining). Indeed, synovial Pdpn expression remained 
comparable in WT and Il27ra/ mice (Fig. 5 B). Whereas 
draining LNs from Il27ra/ mice with AIA showed no in-
crease in the total number of CD4+Pdp+ T cells (Fig. 5 C), an 
increased number of Pdp+ Th17 cells were detected (Fig. 5 D). 
IL-27 regulates synovial ELS through inhibition of homeo-
static chemokines, lymphoid cytokines, and transcriptional 
regulators involved in lymphoid neogenesis.
IL-27 inhibits effector T cells linked with ELS formation
Recent studies have highlighted novel roles for effector T cell 
subsets, such as Th17 and Tfh cells, in ectopic lymphoid neo-
genesis and the control of GC reactions (Lu et al., 2011; 
Peters et al., 2011; Rangel-Moreno et al., 2011; Hirota et al., 
2013). Thus, cytokines linked with either T cell differentia-
tion or plasticity of effector T cells into Tfh-like phenotypes 
may regulate ELS involvement in chronic disease (Lu et al., 
2011; Peters et al., 2011; Hirota et al., 2013). As IL-27 inhib-
its effector Th17 responses, we considered the expression of 
Th17 and Tfh cell markers within the inflamed synovium. At 
d10 of AIA, formation of ELS in Il27ra/ mice was associ-
ated with increases in Il17a and the Tfh markers Bcl6 and Il21 
(Fig. 4 B). No differences in Il10 and Il7 were observed 
between WT and Il27ra/ mice.
The transcription factor STAT3 regulates Th17 and Tfh cell 
responses and is linked with lymphoid neogenesis and GC 
activities. In experimental arthritis, gp130-mediated STAT3 
signaling exacerbates pathology (Atsumi et al., 2002; Nowell 
et al., 2009), and synovial tissues containing lymphoid follicles 
show enhanced STAT3 activity (Sawa et al., 2006; Timmer 
et al., 2007). IHC of infiltrating synovial leukocytes for tyrosine 
Figure 4. Synovial expression of ELS-associated signa-
ture genes in AIA. (A and B) qPCR of indicated genes in WT 
and Il27ra/ mice at d10 of AIA (n = 15/group). Data are 
from three independent experiments. (C) Representative IHC 
of CD3 and phosphorylated (pY)-STAT3 synovial infiltrates  
in sequential sections at d10 of AIA in Il27ra/ mice. Corre-
sponding areas are boxed. Images are representative of four 
Il27ra/ sections with ELS. Error bars indicate SEM. *,  
P < 0.05; **, P < 0.01; ***, P < 0.001. Bars, 200 µm.
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data, IL17 and IL21 were elevated in patients with ELS+ sy-
novitis, whereas no IL17 transcripts were detected in patients 
with diffuse pathology (Fig. 6 A). PDPN, BCL6, and IL10 
expression was comparable in both patient groups. Consis-
tent with data presented in Fig. 5 G, IF again confirmed the 
localization of Pdp in T cell–rich lymphoid aggregates in 
ELS+ synovia (Fig. 6 B). Although Pdp expression was also 
seen in lymphatic compartments and synovial lining, it is per-
haps significant that Pdp was only observed in ELS featuring 
full T/B cell segregation. Thus, Pdp detection in ELS may 
indicate functional GCs.
To link synovial histopathology with IL-27 involvement, 
expression of IL-27p28 (IL27) and Epstein-Barr virus-induced 
gene-3 (EBI3) were quantified in ELS+ and ELS RA patient 
biopsies and OA control tissue. Expression of IL27 was sig-
nificantly higher in ELS RA patients compared with ELS+ 
RA and OA biopsies (Fig. 6 C). Although EBI3 showed a 
similar pattern of expression, the increase in ELS tissue was 
not significant (P = 0.8360; Fig. 6 C). Detection of IL27 
To determine if IL-27 could suppress Pdp+ Th17 cell develop-
ment, naive CD4 T cells were cultured under Th17-polarizing 
conditions and expression of IL-17 and Pdp was assessed by 
flow cytometry (Fig. 5, E and F). Although IL-27 had a mod-
est impact on the number of total CD4 cells expressing Pdp, 
IL-27 preferentially inhibited the expansion of Pdp+IL-17+ 
CD4 cells (Fig. 5, E and F). Subsequent IF studies of the in-
flamed synovium of Il27ra/ mice revealed a colocalization of 
Pdp and CD3 in lymphoid aggregates (Fig. 5 G). Thus, syno-
vial ELS in Il27ra/ mice are associated with an increase in 
synovial Th17 and Tfh effector cytokines and peripheral Pdp+ 
Th17 cell numbers. Therefore, IL-27 negatively regulates ELS 
development at sites of chronic inflammation through a poten-
tial impact on Th17 cells that can acquire Tfh-like properties.
IL-27 expression is decreased in lymphoid-rich synovitis
To translate our animal studies to clinical RA, expression of 
Th17/Tfh signatures were examined in synovial biopsies 
from ELS+ and ELS RA patients. In line with our mouse 
Figure 5. Pdp-expressing T helper cells 
are found at synovial ELS in Il27ra/ 
mice. (A–D and G) AIA was established in WT 
and Il27ra/ mice, and pathology was as-
sessed at d10. (A) IHC of serial sections 
stained for CD3, B220, and Pdp in Il27ra/ 
mice. ELS in sequential sections are shown 
boxed. Images are representative of four sec-
tions from two independent experiments.  
(B) qPCR of synovial Pdpn expression (n = 15/
group from 3 independent experiments).  
(C and D) Number of Pdp+ CD4 cells (C) and 
IL-17+ and IL-17+Pdp+ Th17 cells (D) in ingui-
nal LNs determined by flow cytometry (n =  
8–9/group). Data are representative of two 
independent experiments. (E and F) WT CD4  
T cells were activated under Th17-polarizing 
conditions with the indicated amount of IL-27 
(0–100 ng/ml). Pdp+ Th17 cell differentiation 
was determined by flow cytometry. Represen-
tative flow cytometry (E) and graphs (n = 3 
mice) showing the number of CD4+Pdp+  
T cells and CD4+IL-17+Pdp+ T cells (Pdp+ Th17 
cells; F) after 4 d of culture. E and F are repre-
sentative of three independent experiments. 
(G) Detection of Pdp+ T cells at synovial ELS  
in Il27ra/ mice by IF for Pdp and CD3 with 
DAPI nuclear staining. Images are representa-
tive of four sections from two independent 
experiments. Error bars indicate SEM. *, P < 
0.05; **, P < 0.01. Bars: (A) 300 µm left, 200 µm 
right; (G, left) 200 µm left; (G, merged  
image) 100 µm.
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ELSs. Although the mechanisms determining lymphoid-rich 
synovitis remains undefined, the ability to stratify patients 
with signature biomarkers such as IL27 has the potential to 
inform treatment decisions by ensuring patients receive the 
most efficacious form of therapy for their type of disease.
MATERIALS AND METHODS
Clinical patient samples. Synovial tissue was collected from a total of 59 
RA patients fulfilling the ACR criteria and undergoing arthroplastic surgery 
(n = 23) or ultrasound-guided synovial biopsy (n = 36) and 13 OA patients 
who underwent total joint replacement as control samples. Demographic 
data are provided in Table S1. The majority of patients had received stable-dose 
methotrexate, and none were on biologics. Paired paraffin-embedded tissue 
and RNA samples were prepared from all patients to allow cross-referencing 
between histological assessments and qPCR gene expression analysis. Proce-
dures were approved by the hospital Ethics Committee (REC/98/11/27 
Guys and St. Thomas’ NHS Trust and REC 05/Q0703/198 Barts and The 
London NHS Trust) and performed after informed written consent.
For histological grading of tissues, 5-µm paraffin-embedded sections 
were stained with hematoxylin and eosin (H&E) to define the predominant 
histomorphological pattern of RA synovitis as either diffuse or aggregate. 
Synovial inflammation was graded as described previously (Humby et al., 
2009), which is based on the enlargement of the synovial lining cell layer 
(score 0–3), the density of resident cells (0–3) and the extent of the inflam-
matory infiltrate (0–3) to yield a score ranging between 0 and 9. The degree 
of immune cell infiltration was further characterized by IHC using a 
inversely correlated with synovitis and CD3 and CD20 infil-
tration. However, no correlation was observed between IL27 
and IHC staining for CD138, or the myeloid marker CD68 
(Fig. 6 D). Thus, IL27 expression shows an inverse relation-
ship to molecular signatures of ELS organization and function 
(Fig. 1 B). Synovial IL27 expression is therefore predictive of 
patients with diffuse synovial histopathology and is consistent 
with the action of IL-27 as an inhibitor of ELS. Whereas the 
mechanism responsible for the pattern of IL27 expression in 
different forms of synovitis is unclear, this likely reflects either 
inhibition of gene expression in ELS+ patients or a specific 
induction in ELS patients.
Early intervention is the most effective treatment for in-
flammatory arthritis. However, in the absence of reliable bio-
markers, clinical criteria alone cannot predict the course of 
disease or the most suitable therapy for intervention. Defined 
patterns of synovial pathology emphasize the heterogeneity 
of RA progression and illustrate the importance of advances 
in biopsy techniques and diagnosis. Individuals with ELS+ 
synovitis remain challenging to treat and typically respond 
poorly to anti-TNF (Cañete et al., 2009; Manzo et al., 2010). 
Our data shows that IL27 is predictive of synovitis with dif-
fuse inflammatory infiltrates, rather than highly organized 
Figure 6. IL-27 expression reflects syno-
vial histopathology in RA. (A) qPCR analysis 
of the indicated genes in synovia from ELS+ 
and ELS RA patients (IL17, n = 23 ELS+,  
n = 16 ELS; IL21, n = 28 ELS+, n = 20 ELS; 
PDPN, BCL6, and IL10, n = 13 ELS+, n = 12 
ELS). (B) Detection of Pdp+ cells at synovial 
ELS by IF for Pdp and CD3 with DAPI nuclear 
staining. Images are representative of three 
tissue samples. (C) qPCR of IL27 and EBI3 
expression in ELS+ and ELS RA synovia, and 
OA control patients (n = 19 ELS+, n = 14 ELS, 
n = 11 OA). (D) Synovial IL27 gene expression 
plotted against synovitis and IHC scores for 
CD3, CD20, CD138, and CD68 cells. Error bars 
indicate SEM; *, P < 0.05; **, P < 0.01.  
Bars, 50 µm.
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Clinical patient synovial samples were stored in RNAlater at 80°C. 
RNA was recovered as above using the RNeasy Mini kit (QIAGEN) and 
cDNA prepared using the Thermoscript RT-PCR System for Fist-Strand 
cDNA Synthesis kit (Invitrogen). Gene expression was quantified using 
TaqMan primers, probes, and reaction buffers and acquired on a 7900HT 
Fast Real Time PCR System (all Life Technologies). Genes were normalized 
against the expression of the housekeeping genes for 18S rRNA and GAPDH.
Immunohistochemistry. Leukocyte and follicular markers were detected 
in paraffin sections using primary antibodies to murine CD3 (Dako), F4/80 
(AbD Serotec), B220 (BD), CD21, and Bcl-6 (Santa Cruz Biotechnology, 
Inc.) and podoplanin (BioLegend). Antigen unmasking was achieved by 
heating in 10 mM sodium citrate buffer containing 0.05% (wt/vol) Tween 
20 (95°C, 40 min). For F4/80 staining, antigen retrieval was performed by 
incubating with 0.05% (wt/vol) Trypsin-EDTA (37°C, 30 min). Endoge-
nous peroxidase and biotin activity was blocked using 3% (vol/vol) H2O2 and 
an avidin/biotin blocking kit (Vector Laboratories), respectively. Sections 
were incubated in serum appropriate to the secondary antibody before pri-
mary antibody incubations. Antibody labeling was detected using biotinylated 
secondary antibodies (Dako), the Vectastain ABC kit and diaminobenzidine 
chromagen (Vector Laboratories). Sections were counterstained with hema-
toxylin. The Leica QWin microscope imaging software was used for quanti-
fication of staining. Colocalization of lymphoid cells was determined by 
staining of serial, sequential sections.
Immunofluorescence. Paraffin-embedded sections were rehydrated be-
fore antigen unmasking by incubating in target retrieval solution (Dako) at 
95°C for 35 min for human synovium or 10 mM sodium citrate buffer con-
taining 0.05% (wt/vol) Tween 20 (95°C, 40 min) for mouse. Endogenous 
biotin activity was blocked using the avidin/biotin blocking kit (Vector 
Laboratories). Human synovial sections were incubated with serum-free 
protein block (Dako) before incubation with goat anti–human IL-27R 
(R&D Systems), mouse anti–human podoplanin, or mouse anti–human 
CD3 (both Dako). Mouse sections were blocked with goat serum before 
incubation with antibodies to podoplanin (BioLegend) or CD3 (Dako). Anti-
body labeling was detected using combinations of biotinylated and Alexa 
Fluor 488–conjugated secondary antibodies, and Alexa Fluor 555 or APC-
conjugated streptavidin. Slides were counter stained with DAPI and mounted 
with Mowiol.
In vitro T cell cultures. Naive CD4 T cells (CD4+CD25CD44loCD62Lhi) 
cells were cultured in RPMI-1640 supplemented with 10% (vol/vol) FCS, 
2 mM l-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 1 mM 
sodium pyruvate, and 50 µM 2-mercaptoethanol (all from Invitrogen). 105 cells 
were cultured in 96-well plates coated with anti-CD3 (1 µg/ml; 145-2C11) 
and soluble anti-CD28 (5 µg/ml; 37.51). Cultures contained recombinant 
TGF (1 ng/ml) and IL-6 (20 ng/ml) with or without IL-27 (1–100 ng/ml) 
as indicated.
Flow cytometry. Inguinal LNs were recovered and single-cell suspensions 
prepared and analyzed by flow cytometry. For intracellular cytokine staining, 
cells were cultured with PMA (50 ng/ml), ionomycin (500 ng/ml), and mo-
nensin (3 µM; all from Sigma-Aldrich) for 4 h. Cells were stained for cell 
surface markers, then fixed and permeabilized in Cytofix/Cytoperm (BD) 
before intracellular detection of cytokines. Flow cytometric analysis of cells 
was performed using anti-CD4 (RM4-5), anti-CD3 (17A2), anti-IL-17 
(TC11-18H10.1), anti-IFN- (XMG1.2), and anti-podoplanin (8.1.1). Cells 
were acquired using a FACSCanto II (BD) or CyAn ADP (Beckman Coulter) 
flow cytometer and analyzed using FlowJo software (Tree Star). Cell numbers 
were determined by multiplying the percentage obtained by flow cytometry 
with the total cell count.
Enzyme-linked immunosorbent assay (ELISA). IL-17A levels were 
determined in mouse serum using a commercial murine IL-17A ELISA kit 
(BioLegend). Serum antibody titers to mBSA were determined by coating 
semi-quantitative analysis which grades (0–4) the degree of CD3 (T cells), 
CD20 (B cells), CD138 (plasma cells), and CD68 (macrophages) staining in 
the synovial and subsynovial lining (Fig. S1). To define the presence of ectopic 
lymphoid follicles, lymphoid aggregates were counted in each section and 
graded as described previously (Manzo et al., 2005; Humby et al., 2009), as 
grade 1 (G1) aggregates displaying a 2–5 radial cell number from a central 
blood vessel, grade 2 (G2), between 6–10 cells, or grade 3 (G3), with >10 cells. 
IHC staining for CD3, CD20, and CD21 was further used to confirm T/B cell 
segregation and the presence of follicular DC networks. Tissue with maxi-
mal G3 aggregates, staining positive for CD21 and displaying well-organized 
lymphoid structures, were defined as ELS+. To minimize bias caused by 
anomalies in serial sectioning, all paraffin-embedded blocks were cut and 
stained at three levels 50 µm apart.
Animals. Il27ra/ mice have been described previously (Yoshida et al., 
2001). Mice were on a C57BL/6 background and were bred under specific 
pathogen–free conditions at Monash Institute of Medical Research (Clayton, 
Victoria, Australia) and Cardiff University (Cardiff, Wales). All experiments 
were endorsed by the Monash University Animal Ethics Committee and 
UK Home Office-approved project license PPL 30/2928.
Murine AIA. AIA was established in adult (8–12 wk) Il27ra/ mice and 
age/sex-matched WT controls, as described previously (Nowell et al., 2009). 
In brief, mice were immunized by subcutaneous administration of 100 µl 
mBSA (1 mg/ml; Sigma-Aldrich) emulsified in an equal volume of Com-
plete Freund’s Adjuvant (CFA). To prime the immune response, mice also 
received 160 ng of heat-inactivated Bordetella pertussis toxin as a single intra-
peritoneal injection (Sigma-Aldrich). 1 wk later, mice were reimmunized 
with an identical subcutaneous administration of mBSA in CFA. 21 d after 
the initial immunization, inflammatory arthritis was triggered by intraarticu-
lar administration of 10 µl mBSA (10 mg/ml) in the right stifle joint. Animals 
were inspected daily for arthritis development by measuring knee joint di-
ameters using a POCO 2T micrometer (Kroeplin). A minimum of six animals 
per time point was culled at intervals (days 3, 10, and 35) over the course of 
the disease, and joint pathology assessed histologically. Accumulative arthritic 
scores were generated according to the severity of synovial infiltration, exu-
date, hyperplasia, and joint erosion (see below).
Knee joints were fixed in neutral buffered formalin (10% vol/vol) and 
decalcified in 10% (vol/vol) formic acid at 4°C before embedding in paraffin. 
Midsagittal serial sections (7 µm thick) were stained with H&E. For evalua-
tion of bone and cartilage erosion, sections were stained with Safranin O and 
Fast Green (Sigma-Aldrich). Two independent observers, blinded to the 
experimental groups, scored the sections for subsynovial inflammation 
(0 = normal to 5 = ablation of adipose tissue due to leukocyte infiltrate), 
synovial exudate (0 = normal to 3 = substantial number of cells with large 
fibrin deposits), synovial hyperplasia (0 = normal 1–3 cells thick to 3 = over 
3 layers thick with overgrowth onto joint surfaces with evidence of cartilage/
bone erosion), and cartilage/bone erosion (0 = normal to 3 = destruction of 
a significant part of the bone). The aggregate score for all parameters is pre-
sented as an arthritic index.
Quantitative real-time PCR. For mouse samples, the inflamed synovium 
was recovered by dissection before storing in RNAlater (Ambion) at 80°C. 
Total cellular RNA was extracted using TRIsure reagent (Bioline) and fur-
ther purified using the RNeasy Mini kit with on-column DNase treatment 
(QIAGEN). RNA was converted to cDNA using the nanoScript 2 Reverse 
Transcription kit (Primerdesign). Expression of mouse genes was determined 
using the 7900HT Fast or the QuantStudio 12K Flex Real-Time PCR Sys-
tem, and data acquisition and analyses were performed using the Sequences 
Detection System Version 2.3 software and ExpressionSuite software version 
1.0.3 (all from Life Technologies). Sequences of primers used with SYBR 
Green reagents (Invitrogen) can be seen in Table S2. All other genes were 
analyzed using TaqMan primers, probes, and reaction buffers (Life Technol-
ogies). Genes were normalized against the expression of the housekeeping 
genes for 18S rRNA and ACTB.
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Statistics. Statistical analysis was performed using GraphPad Prism software. 
For assessment of arthritic indices, significant differences were determined 
using the nonparametric Mann Whitney U test. Otherwise, statistical differ-
ences were determined using the unpaired Student’s t test. Where experi-
mental groups were compared across multiple time points, a two-way analysis 
of variance (ANOVA) was used with the Bonferroni post-test. For clinical 
samples, data displaying nonnormal distribution was analyzed using the non-
parametric Mann Whitney U test. Normally distributed data were analyzed 
using the Student’s t test. P < 0.05 was considered significant. Graphs repre-
sent mean ± SEM.
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able at http://www.jem.org/cgi/content/full/jem.20132307/DC1.
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